A native arteriovenous fistula (AVF) represents the optimal form of Vascular Access (VA) for patients receiving hemodialysis (HD). In Libya there are several barriers to AVF creation including lack of adequate preparation for dialysis and surgical services. We aimed to conduct the first comprehensive study of VA utilisation in HD patients in Libya.
Methods
A prospective observational study included all adult patients receiving HD treatment in 25 HD facilities in Libya from May 2009 to Nov 2011. Researchers gathered data regarding VA through interviews with staff and patients as well as medical records. Patients with definitive VA were re-interviewed after 1 year.
Results
At baseline the majority of patients (91.9%; n=1573) were using permanent VA in the form of AVF or arteriovenous graft. Patients with permanent VA were more likely to be male and less likely to be diabetic than those with CVCs. Most patients had commenced HD using a temporary CVC (91.8%). VA-related complications were: thrombosis (46.7%), aneurysm (22.6%), infection (11.5%) and haemorrhage (10.2%). Incident VA thrombosis was reported by 14.7% in 1 year. Independent risk factors for incident thrombosis were female gender and diabetes. Hospitalisation for VA related complications was reported by 31.4%.
Conclusions
Few patients in Libya initiate HD with definitive VA, but most achieve it thereafter. Improved dialysis preparation and increased provision of surgical services are required to increase the proportion of patients initiating HD with definitive VA and should be a priority in rebuilding health services in Libya after the recent conflict.
StevensonK.B., AdcoxM.J., MalleaM.C., NarasimhanN., WagnildJ.P.Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center.Infection control and hospital epidemiology: Infect Control Hosp Epidemiol.2000; 21(3): 200–203.
2.
TokarsJ.I.Description of a new surveillance system for bloodstream and vascular access infections in outpatient hemodialysis centers.Semin Dial.2000; 13(2): 97–100. doi: 10.1046/j.1525-139x.2000.00030.x. Medline
NeumannM.E.“Fistula first” initiative pushes for new standards in access care.Nephrol News Issues.2004; 18(9): 43, 7-8.
5.
AllonM.Current management of vascular access.Clin J Am Soc Nephrol.2007; 2(4): 786–800. doi: 10.2215/CJN.00860207. Medline
6.
AstorB.C., EustaceJ.A., PoweN.R., KlagM.J., FinkN.E., CoreshJ.; CHOICE Study. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.J Am Soc Nephrol.2005; 16(5): 1449–1455. doi: 10.1681/ASN.2004090748. Medline
7.
Vascular Access 2006 Work Group.Clinical practice guidelines for vascular access.Am J Kidney Dis.2006; 48(Suppl 1): S176–S247. doi: 10.1053/j.ajkd.2006.04.029. Medline
8.
AfifiA., KarimM.A.Renal replacement therapy in Egypt: first annual report of the Egyptian Society of Nephrology, 1996.East Mediterr Health J.1999; 5(5): 1023–1029 Medline.
MedkouriG., AghaiR., AnabiA.. Analysis of vascular access in hemodialysis patients: a report from a dialysis unit in Casablanca.Saudi J Kidney Dis Transpl.2006; 17(4): 516–520 Medline.
11.
AfifiA., RefaatH., WahbaA.M.. Hemodialysis vascular access among chronic renal failure patients in Egypt.J Vasc Access.2002; 3(4): 164–168 Medline.
12.
FaragY.M.K., Al WakeelJ.S.Diabetic nephropathy in the Arab Gulf countries.Nephron Clin Pract.2011; 119(4): c317–c322, discussion c322-c323. doi: 10.1159/000328909. Medline
13.
SandersC., DeshmukhM., AstorD., KranzR.G., DaldalF.Overproduction of CcmG and CcmFH(Rc) fully suppresses the c-type cytochrome biogenesis defect of Rhodobacter capsulatus CcmI-null mutants.J Bacteriol.2005; 187(12): 4245–4256. doi: 10.1128/JB.187.12.4245-4256.2005. Medline
14.
FiorinaP., GremizziC., MaffiP.. Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients.Diabetes Care.2005; 28(6): 1358–1365. doi: 10.2337/diacare.28.6.1358. Medline
15.
CollinsA.J., FoleyR.N., ChaversB.. ‘United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.Am J Kidney Dis.2012; 59(1 Suppl 1): A7, e1-420.
16.
LynchJ.R., MohanS., McClellanW.M.Achieving the goal: results from the Fistula First Breakthrough Initiative.Curr Opin Nephrol Hypertens.2011; 20(6): 583–592. doi: 10.1097/MNH.0b013e32834b33c4. Medline
17.
LynchJ.R., WasseH., ArmisteadN.C., McClellanW.M.Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients.Am J Kidney Dis.2011; 57(1): 78–89. doi: 10.1053/j.ajkd.2010.08.028. Medline
18.
AlashekW.A., McIntyreC.W., TaalM.W.Provision and quality of dialysis services in Libya.Hemodial Int.2011; 15(4): 444–452. doi: 10.1111/j.1542-4758.2011.00588.x. Medline
19.
RaynerH.C., PisoniR.L., GillespieB.W..; Dialysis Outcomes and Practice Patterns Study. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study.Kidney Int.2003; 63(1): 323–330. doi: 10.1046/j.1523-1755.2003.00724.x. Medline
20.
AllonM., OrntD.B., SchwabS.J..; Hemodialysis (HEMO) Study Group. Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study.Kidney Int.2000; 58(5): 2178–2185. doi: 10.1111/j.1523-1755.2000.00391.x. Medline
21.
MarcusR.J., MarcusD.A., SureshkumarK.K., HussainS.M., McGillR.L.Gender differences in vascular access in hemodialysis patients in the United States: developing strategies for improving access outcome.Gend Med.2007; 4(3): 193–204. doi: 10.1016/S1550-8579(07)80040-4. Medline
22.
VernaglioneL., MeleG., CristofanoC.. Comorbid conditions and gender impact the primary survival of distal radio-cephalic arteriovenous fistula inpatients on long-term hemodialysis.J Nephrol.2005; 18(3): 276–281 Medline.
23.
AllonM., LockhartM.E., LillyR.Z.. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients.Kidney Int.2001; 60(5): 2013–2020. doi: 10.1046/j.1523-1755.2001.00031.x. Medline
24.
MillerC.D., RobbinM.L., AllonM.Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients.Kidney Int.2003; 63(1): 346–352. doi: 10.1046/j.1523-1755.2003.00740.x. Medline
25.
HirthR.A., TurenneM.N., WoodsJ.D.. Predictors of type of vascular access in hemodialysis patients.JAMA.1996; 276(16): 1303–1308. doi: 10.1001/jama.1996.03540160025028. Medline
26.
GheithO.A., KamalM.M.Risk factors of vascular access failure in patients on hemodialysis.Iran J Kidney Dis.2008; 2(4): 201–207 Medline.
27.
RitzE., RychlíkI., LocatelliF., HalimiS.End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.Am J Kidney Dis.1999; 34(5): 795–808. doi: 10.1016/S0272-6386(99)70035-1. Medline
28.
LeapmanS.B., BoyleM., PescovitzM.D., MilgromM.L., JindalR.M., FiloR.S.The arteriovenous fistula for hemodialysis access: gold standard or archaic relic?Am Surg.1996; 62(8): 652–656, discussion 656-657 Medline.
29.
HammesM., FunakiB., CoeF.L.Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis.Hemodial Int.2008; 12(1): 85–89. doi: 10.1111/j.1542-4758.2008.00246.x. Medline
HakimR., HimmelfarbJ.Hemodialysis access failure: a call to action.Kidney Int.1998; 54(4): 1029–1040. doi: 10.1046/j.1523-1755.1998.00122.x. Medline
32.
NgL.J., ChenF., PisoniR.L.. Hospitalization risks related to vascular access type among incident US hemodialysis patients.Nephrol Dial Transplant.2011; 26(11): 3659–3666. doi: 10.1093/ndt/gfr063. Medline
